Not Signed In - Chronic Lymphoblastic Leukaemia - Fludarabine with alemtuzumab (FluCam) gives over 80% response rate
Tue, 07 Jun 2005 10:00 AM EST
... A 4-weekly combination of fludarabine and alemtuzumab (FluCam) for patients with relapsed chronic lymphoblastic leukaemia (CLL) has shown an overall response rate of 83% in 36 patients in a phase II trial... click link for more info. ...
Related Topics
- Disaster Response
- Alemtuzumab
- Chronic Fatigue Syndrome
- Pain - Chronic
- Chronic Pain
- Chronic Diseases
- Leukemia
- Emergency Preparedness & Response
- Theophylline Tablets or Capsules
- Theophylline Oral Solution, Syrup, or Suspension
- Infant Mortality
- Adult Acute Lymphoblastic Leukemia
- Glomerular Filtration Rate
- Leukemia, Chronic Lymphocytic
- Chronic Lymphocytic Leukemia
- Childhood Acute Lymphoblastic Leukemia
- Leukemia, Acute Lymphoblastic, Adult
- Acute Lymphoblastic Leukemia, Childhood
- Leukemia, Acute Lymphoblastic, Childhood
- Chronic Obstructive Pulmonary Disease
email this page
print this page
bookmark this page
feedback on this page
